Effect of pre-hospitalization use of oral antiviral agents on reducing critical illness and mortality for patients with COVID-19 pneumonia
Journal
International journal of antimicrobial agents
Journal Volume
63
Journal Issue
1
Date Issued
2024-01
Author(s)
Yii, Yong-Cheng
Shih, Hong-Mo
Chen, Chieh-Lung
Lai, Zi-Lun
Hsu, Yu-Lung
Lai, Chia-Hong
Cho, Der-Yang
Abstract
This study aimed to evaluate the effect of administering nirmatrelvir/ritonavir and molnupiravir before hospitalisation on subsequent critical illness among patients with COVID-19 pneumonia.
Subjects
COVID-19; Critical illness; Molnupiravir; Nirmatrelvir/ritonavir; Oral antivirals; Vaccine
Type
journal article